Oxyindole derivatives as 5HT4 receptor agonists

Details for Australian Patent Application No. 2006217534 (hide)

Owner Pfizer Inc.,

Inventors Sone, Hiroki; Kawamura, Kiyoshi; Uchida, Chikara

Agent Allens Arthur Robinson

Pub. Number AU-B-2006217534

PCT Pub. Number WO2006/090279

Priority 60/655,276 22.02.05 US

Filing date 10 February 2006

Wipo publication date 31 August 2006

Acceptance publication date 11 August 2011

International Classifications

C07D 405/14 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

A61K 31/454 (2006.01)

A61P 1/04 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

2 August 2007 PCT application entered the National Phase

  PCT publication WO2006/090279 Priority application(s): WO2006/090279

11 August 2011 Application Accepted

  Published as AU-B-2006217534

8 December 2011 Standard Patent Sealed

8 December 2011 Corrigenda

  Applications Accepted - Name Index Under the name Pfizer Inc.,, Application No. 2006217534, under INID (71) correct the applicant name to Pfizer Inc.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006217540-Ocaperidone salts and pharmaceutical compositions containing the same

2006217529-Crystalline ACAT inhibitor